prof.dr. M.J. IJzerman (Maarten)

Maarten J. IJzerman is professor and head of Cancer Health Services Research in the University of Melbourne and Peter MacCallum Cancer Centre and a part-time professor in the University of Twente's TechMed Centre. His international work is focussed on the health economics and health services implications of personalised medicine, including drug treatment sequencing and the use of complex genomic sequencing. He develops and applies new methods for value assessment of medical technologies, in particular molecular diagnostics for precision oncology. He is a pioneer in the field of early Health Technology Assessment, supporting the clinical translation of medical innovation by modelling their health and economic impact in an early stage of development.

Before moving to Melbourne in 2018, he was the founding chair of the Department of Health Technology and Services Research (2007-2015), director of education for Health Sciences program (2007-2011), acting director of the MIRA institute for Biomedical Engineering and Technical Medicine (2013-2014) and vice-dean for Health & Biomedical Technology in the Faculty of Science and Technology (2015-2017). Before then, he worked as a visiting scholar in different academic centres in the USA and Canada and was the scientific director of Roessingh Research and Development (2000-2007).

Maarten has supervised many MSc and PhD students in several UT degree programs (TM, HS, BME and IEM) and is a mentor to early-to-mid career academics globally.

Social Sciences

# Cancer
# Health Economics

Medicine & Life Sciences

# Cost-Benefit Analysis
# Costs And Cost Analysis
# Decision Support Techniques
# Delivery Of Health Care
# Economics
# Health

Faculty of Behavioural, Management and Social Sciences (BMS), Health Technology & Services Research (HTSR)

Erasmus University Rotterdam
Academic, fulltime position
Laboratorium Microbiologie
Raad van Toezicht

van Delft, F. A., Schuurbiers, M. M. F., Muller, M., Burgers, S., van Rossum, H. H. , IJzerman, M. J., van den Heuvel, M. M. , & Koffijberg, H. (2023). Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer. Tumor Biology. https://doi.org/10.3233/TUB-220022

van Delft, F. A. (2023). Optimizing the use of blood based biomarkers to improve the clinical management of advanced non-small cell lung cancer. [PhD Thesis - Research UT, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789036557306

Rizvi, F., Wilding, H. E., Rankin, N. M., Le Gautier, R., Gurren, L., Sundararajan, V., Bellingham, K., Chua, J., Crawford, G. B., Nowak, A. K., Le, B., Mitchell, G., McLachlan, S. A., Sousa, T. V., Hudson, R. , IJzerman, M., Collins, A., & Philip, J. (2023). An evidence-base for the implementation of hospital-based palliative care programs in routine cancer practice: A systematic review. Palliative Medicine. https://doi.org/10.1177/02692163231186177

van Til, J. A. , Kip, M. M. A., Schatorjé, E. J. H., Currie, G., Twilt, M., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N., Yeung, R. S. M. , Groothuis-Oudshoorn, C. G. M. K., Warta, S., Marshall, D. A. , IJzerman, M. J., & UCAN CAN-DU, UCAN CURE consortia (2023). Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists? Pediatric rheumatology online journal, 21(1), 69. [69]. https://doi.org/10.1186/s12969-023-00845-4

Drosdowsky, A., Lamb, K. E., Bergin, R. J., Boyd, L., Milley, K. , IJzerman, M. J., & Emery, J. D. (2023). A systematic review of methodological considerations in time to diagnosis and treatment in colorectal cancer research. Cancer epidemiology, 83, [102323]. https://doi.org/10.1016/j.canep.2023.102323

To, Y. H., Gibbs, P., Tie, J. , IJzerman, M., & Degeling, K. (2023). Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review. Cost effectiveness and resource allocation, 21(1), [11]. https://doi.org/10.1186/s12962-023-00422-2

O’Haire, S., Franchini, F., Kang, Y. J., Steinberg, J., Canfell, K., Desai, J., Fox, S. , & IJzerman, M. (2023). Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours. Scientific reports, 13(1), [4116]. https://doi.org/10.1038/s41598-023-31055-3

Fagery, M., Khorshidi, H. A., Wong, S. Q., Vu, M. , & IJzerman, M. (2023). Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review. PharmacoEconomics, 41(10), 1229-1248. https://doi.org/10.1007/s40273-023-01292-5

Currie, G. R. , Groothuis-Oudshoorn, C. G. M., Twilt, M. , Kip, M. M. A. , IJzerman, M. J., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R., & Marshall, D. A. (2023). What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey. Clinical rheumatology, 42(8), 2173-2180. https://doi.org/10.1007/s10067-023-06616-6

Behr, C. M., Oude Wolcherink, M. J. , IJzerman, M. J., Vliegenthart, R. , & Koffijberg, H. (2023). Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations. PharmacoEconomics, 41, 395-411. https://doi.org/10.1007/s40273-022-01238-3

See all research output of this employee

View my profile

I am committed to teaching in graduate programs in the University of Twente and Melbourne as well as international short-courses for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Master

Industrial Engineering and Management

Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.

193650999 - Masters Assignment

https://www.utoday.nl/covid-19-research-at-ut/68467/delays-in-cancer-treatments-due-to-corona-crisis
https://www.utwente.nl/en/news/2018/3/39094/maarten-ijzerman-to-lead-world-class-cancer-research-program-in-melbourne

Tweets by maartenijzerman

+31534893684

+61385598585

+31534897475 (if no answer)

m.j.ijzerman@utwente.nl

maarten.ijzerman@unimelb.edu.au